IMGN Immunogen Inc

Immunogen Inc is a clinical-stage biotechnology company that develops targeted anticancer therapeutics. It has developed its ADC technology to enable the creation of anticancer products.

$8.75  +0.39 (4.61%)
As of 03/05/2021 14:52:38 EST     IEX book   CBOE book


Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Small cap
Health Care
Biotechnology
USA
USA
02/20/2001
199,731,834
3,396,663
$1,669,758,132
0.00%
SEC Edgar Online
10-Q
10-K
45253H101
US45253H1014
2457864

Valuation   (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
-37.63
18.21
12.62
-49.54%
-33.54%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy